Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SCN1B and SCN2B gene variants analysis in dravet syndrome patients: Analysis of 22 cases.

Medicine·2019
Same author

Modulation of drug release by decoration with Pluronic F127 to improve anti-colon cancer activity of electrospun fibrous meshes.

Materials science & engineering. C, Materials for biological applications·2019
Same author

Nontarget metabolomics profiling of neuromyelitis optica spectrum disorder.

Biomedical chromatography : BMC·2019
Same author

Expression of Nav1.5 in the pathogenesis of temporal lobe epilepsy.

Cellular and molecular biology (Noisy-le-Grand, France)·2019
Same author

Circ_0075932 in adipocyte-derived exosomes induces inflammation and apoptosis in human dermal keratinocytes by directly binding with PUM2 and promoting PUM2-mediated activation of AuroraA/NF-κB pathway.

Biochemical and biophysical research communications·2019
Same author

Chondroitin sulfate-functionalized polymeric nanoparticles for colon cancer-targeted chemotherapy.

Colloids and surfaces. B, Biointerfaces·2019

Related Experiment Video

Updated: May 16, 2026

Enhanced Gene Delivery and Expression using Intraosseous Injection of Chitosan Nanoparticles Encapsulated Adenine Base Editor Plasmids
07:14

Enhanced Gene Delivery and Expression using Intraosseous Injection of Chitosan Nanoparticles Encapsulated Adenine Base Editor Plasmids

Published on: May 16, 2025

A dual-functionally modified chitosan derivative for efficient liver-targeted gene delivery.

Bo Xiao1, Xiaoyu Wang, Zhiye Qiu

  • 1Advanced Biomaterials and Tissue Engineering Center, Huazhong University of Science and Technology, Wuhan 430074, People's Republic of China.

Journal of Biomedical Materials Research. Part A
|December 4, 2012
PubMed
Summary

Galactosylated hydroxypropyltrimethylammonium (gal-HTCC) shows promise as a liver-targeted gene vector. This novel compound exhibits lower cytotoxicity and enhanced gene transfection efficiency compared to traditional vectors.

More Related Videos

Chitosan/Interfering RNA Nanoparticle Mediated Gene Silencing in Disease Vector Mosquito Larvae
08:36

Chitosan/Interfering RNA Nanoparticle Mediated Gene Silencing in Disease Vector Mosquito Larvae

Published on: March 25, 2015

Efficient Gene Knockdown in the Liver via Intrasplenic Injection of Adeno-Associated Virus Serotype 8 (AAV8)-Delivered Small Hairpin RNA
04:29

Efficient Gene Knockdown in the Liver via Intrasplenic Injection of Adeno-Associated Virus Serotype 8 (AAV8)-Delivered Small Hairpin RNA

Published on: November 1, 2024

Related Experiment Videos

Last Updated: May 16, 2026

Enhanced Gene Delivery and Expression using Intraosseous Injection of Chitosan Nanoparticles Encapsulated Adenine Base Editor Plasmids
07:14

Enhanced Gene Delivery and Expression using Intraosseous Injection of Chitosan Nanoparticles Encapsulated Adenine Base Editor Plasmids

Published on: May 16, 2025

Chitosan/Interfering RNA Nanoparticle Mediated Gene Silencing in Disease Vector Mosquito Larvae
08:36

Chitosan/Interfering RNA Nanoparticle Mediated Gene Silencing in Disease Vector Mosquito Larvae

Published on: March 25, 2015

Efficient Gene Knockdown in the Liver via Intrasplenic Injection of Adeno-Associated Virus Serotype 8 (AAV8)-Delivered Small Hairpin RNA
04:29

Efficient Gene Knockdown in the Liver via Intrasplenic Injection of Adeno-Associated Virus Serotype 8 (AAV8)-Delivered Small Hairpin RNA

Published on: November 1, 2024

Area of Science:

  • Biomaterials Science
  • Gene Therapy
  • Nanotechnology

Background:

  • Chitosan is a biocompatible polymer with potential for gene delivery but lacks targeting specificity.
  • Developing targeted nonviral gene vectors is crucial for efficient and safe gene therapy.
  • Galactosylation can impart specific targeting capabilities to biomaterials.

Purpose of the Study:

  • To synthesize and characterize galactosylated chitosan-hydroxypropyltrimethylammonium (gal-HTCC) as a targeted gene vector.
  • To evaluate the physicochemical properties, cytotoxicity, and gene transfection efficiency of gal-HTCC.
  • To assess the liver-targeting potential of gal-HTCC for gene delivery applications.

Main Methods:

  • Synthesis and characterization of gal-HTCC using FT-IR, NMR, elemental analysis, and X-ray diffraction.
  • Assessment of plasmid condensation capability and nanoparticle formation.
  • In vitro cytotoxicity assays on HepG2 and HeLa cell lines.
  • Confocal laser scanning microscopy for cellular uptake and nuclear transport studies.
  • In vitro gene transfection assays with pGL3 luciferase plasmid in HepG2 cells.

Main Results:

  • Water-soluble gal-HTCC demonstrated an amorphous structure and superior plasmid condensation compared to galactosylated chitosan.
  • gal-HTCC exhibited significantly lower cytotoxicity than branched polyethylenimine (bPEI) in HepG2 and HeLa cells.
  • Nanoparticles formed by gal-HTCC and plasmid DNA had a particle size of approximately 250 nm with narrow distribution.
  • Confocal microscopy confirmed efficient cellular internalization and nuclear transport of NPs within 6 hours.
  • gal-HTCC showed 7- to 32-fold higher transfection efficiency in HepG2 cells compared to chitosan and gal-chitosan, with galactose inhibition confirming targeted uptake.

Conclusions:

  • Galactosylated chitosan-hydroxypropyltrimethylammonium (gal-HTCC) is a promising nonviral gene vector.
  • gal-HTCC possesses enhanced gene delivery efficiency and reduced cytotoxicity.
  • The galactosylation moiety confers liver-targeting specificity, validated by galactose inhibition studies.
  • gal-HTCC represents a viable candidate for efficient, targeted liver gene therapy.